News Releases
Dr. Bamdad will show latest data in presentation “1XX mutations slow CAR T cell signaling and increase in vivo persistence”, Sunday 16th 3:10 – 3:25 in Session: Genetically Engineered Anti-Cancer T Cells in the Valencia BC room.
Minerva will also present a poster "Metastasis: Cancer Cells that have Turned on a Yamanaka-like Pluripotency Program", #2487 Monday, April 17th 1:30 - 5:00 pm. Minerva discovered the onco-embryonic growth factor that drives metastasis and developed a monoclonal antibody that reverses metastasis in animals.